Related Experiment Video
Updated: Nov 4, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Targeting the glycans: A paradigm for host-targeted and COVID-19 drug design
Fatemeh Pourrajab1,2,3
1Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Abstract:
There is always a need for new approaches for the control of virus burdens caused by seasonal outbreaks, the emergence of novel viruses with pandemic potential and the development of resistance to current antiviral drugs. The outbreak of the 2019 novel coronavirus-disease COVID-19 represented a pandemic threat and declared a public health emergency of international concern. Herein, the role of glycans for the development of new drugs or vaccines, as a host-targeted approach, is discussed where may provide a front-line prophylactic or threats to protect against the current and any future respiratory-infecting virus and possibly against other respiratory pathogens. As a prototype, the role of glycans in the coronavirus infection, as well as, galectins (Gal) as the glycan-recognition agents (GRAs) in drug design are here summarized. Galectins, in particular, Gal-1 and Gal-3 are ubiquitous and important to biological systems, whose interactions with viral glycans modulate host immunity and homeostatic balance.
Insights
New strategies are needed to combat viral infections like COVID-19. Targeting host glycans with drugs, particularly using galectins (Gal), offers a promising approach for developing antivirals and vaccines against respiratory viruses.
Area of Science:
- Virology
- Immunology
- Drug Discovery
Background:
- Seasonal outbreaks and novel viruses like COVID-19 necessitate new antiviral strategies.
- Antiviral drug resistance poses a significant public health challenge.
- Host-targeted approaches offer a potential alternative to direct antiviral therapies.
Purpose of the Study:
- To discuss the role of glycans in developing novel drugs and vaccines.
- To explore glycans as a host-targeted prophylactic strategy against respiratory viruses.
- To summarize the function of glycans and galectins (Gal) in coronavirus infections for drug design.
Main Methods:
- Literature review on glycan interactions in viral infections.
- Analysis of galectins (Gal) as glycan-recognition agents (GRAs).
- Focus on Gal-1 and Gal-3 interactions with viral glycans.
Main Results:
- Glycans play a crucial role in viral infections, including coronavirus.
- Galectins (Gal), such as Gal-1 and Gal-3, are key mediators of glycan-viral interactions.
- These interactions modulate host immunity and biological homeostasis.
Conclusions:
- Glycan-based strategies, utilizing galectins, represent a promising avenue for novel antiviral drug and vaccine development.
- This host-targeted approach may provide protection against current and future respiratory pathogens.
- Understanding glycan-galectin interactions is vital for combating viral threats.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein Glycosylation
Glycosylation occurs in...
Glycocalyx and its Functions
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Proteoglycans

